During the past decade, Hopital Bel Air conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hopital Bel Air" are "Erythema Migrans" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Hopital Bel Air" in a lesser frequency.

Most popular intervention types in "Hopital Bel Air" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (1 trials), "Placebo" (1 trials) and "Skin biopsies" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Bel Air" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Bel Air". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hopital Bel Air, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Bel Air, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".